基本信息
views: 96
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Hafeli's research aims to improve drug targeting in cancer therapy. To do this, he is developing radioactive pharmaceuticals (= radiopharmaceuticals), determining their microdosimetry, and then delivering them to different organs and tumours. A particularly fascinating approach to deliver pharmaceuticals that his lab is investigating is magnetic drug targeting. For this purpose, magnetic nanoparticles and microspheres are made that can be physically targeted to cancer cells using magnetic fields.
Research Interests
Papers共 67 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2024): 114180-114180
Molecular pharmaceuticsno. 6 (2024): 2751-2766
European Journal of Pharmaceutics and Biopharmaceutics (2024): 114398-114398
Journal of controlled release (2022): 347-360
Tullio V. F. Esposito, Helene Stutz,Cristina Rodriguez-Rodriguez,Marta Bergamo, Lovelyn Charles,Reka Geczy,Colin Blackadar,Jorg P. Kutter,Katayoun Saatchi,Urs O. Hafeli
Journal of controlled release : official journal of the Controlled Release Society (2020): 375-384
Load More
Author Statistics
#Papers: 68
#Citation: 3333
H-Index: 23
G-Index: 57
Sociability: 5
Diversity: 3
Activity: 10
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn